By Cecilia Butini Merck KGaA on Thursday cut its outlook for the full year due to high inventory levels of customers in its Life Science business and delayed.
By Cecilia Butini Merck KGaA reported results for the second quarter on Thursday. Here is what we watched. SALES: Sales at the Germany-based health-care and.
Health-care companies fell slightly after mixed earnings reports. Moderna shares were more or less flat after the biotech concern, which developed one of the.